Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action

References

• Lockhart SL, Kiedema DJ, Pfaller MA. The epidemiology of fungal infections. In: Anaissie EJ, McGinnis MR, Pfaller MA (eds).Clinical Mycology. 2nd ed. Oxford, UK: Elsevier Inc., 2009. pp. 1–14.
   Google Scholar
• Leroy O, Gangneux JP, Montravers P, . Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 2009; 37: 1612–1618.
   PubMed Web of Science ®Google Scholar
• Stiller ET, Vandeputte J, Wachtel JL. Amphotericins A and B, antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins. Antibiot Annual 1955; 3: 587–591.
   PubMedGoogle Scholar
• Nyfeler R, Keller-Schierlein W.[Metabolites of microorganisms. 143. Echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components]. Helv Chim Acta 1974; 57: 2459–2477. [in German].
   PubMed Web of Science ®Google Scholar
• Huang SX, Zhao LX, Tang SK, . Erythronolides H and I, new erythromycin congeners from a new halophilic actinomycete Actinopolyspora sp. YIM90600. Org Lett 2009; 11: 1353–1356.
   PubMed Web of Science ®Google Scholar
• Huang SX, Powell E, Rajski SR, . Discovery and total synthesis of a new estrogen receptor heterodimerizing actinopolymorphol A from Actinopolymorpha rutilus. Org Lett 2010; 12: 3525–3527.
   Google Scholar
• Yu Z, Zhao LX, Jiang CL, . Bafilomycins produced by an endophytic actinomycete Streptomyces sp. YIM56209. J Antibiot (Tokyo) 2011; 64: 159–162.
   PubMed Web of Science ®Google Scholar
• Huang SX, Yu Z, Robert F, . Cycloheximide and congeners as inhibitors of eukaryotic protein synthesis from endophytic actinomycetes Streptomyces spp. YIM56132 and YIM56141. J Antibiot (Tokyo) 2011; 64: 163–166.
   PubMed Web of Science ®Google Scholar
• Zhao LX, Huang SX, Tang SK, . Actinopolysporins A-C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600. J Nat Prod 2011; 74: 1990–1995.
   PubMed Web of Science ®Google Scholar
• Clemons KV, Miller TK, Selitrennikoff CP, Stevens DA. fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis. Med Mycol 2002; 40: 259–262.
   PubMed Web of Science ®Google Scholar
• Yamada-Okabe T, Mio T, Ono N, . Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans. J Bacteriol 1999; 181: 7243–7247.
   PubMed Web of Science ®Google Scholar
• Bahn YS, Kojima K, Cox GM, Heitman J. A unique fungal two- component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans. Mol Biol Cell 2006; 17: 3122–3135.
   PubMed Web of Science ®Google Scholar
• Nemecek JC, Wuthrich M, Klein BS. Global control of dimorphism and virulence in fungi. Science 2006; 312: 583–588.
   PubMed Web of Science ®Google Scholar
• Zizka Z. Biological effects of macrotetrolide antibiotics and nonactic acids. Folia Microbiol (Praha) 1998; 43: 7–14.
   PubMed Web of Science ®Google Scholar
• Green S, Moehle C. Media and Culture of Yeast. In: Bonifacino JS DM, Harford JB, Lippincott Schwartz J, Yamada KM (eds).Current Protocols in Cell Biology. New York: John Wiley and Sons, Inc., 2001. pp. 1.6.1–1.6.12.
   Google Scholar
• Krajaejun T, Wuthrich M, Gauthier GM, . Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence. Infect Immun 2010; 78: 2522–2528.
   Google Scholar
• Grey M, Brendel M. A ten-minute protocol for transforming Saccharomyces cerevisiae by electroporation. Curr Genet 1992; 22: 335–336.
   Google Scholar
• Motoyama T, Ohira T, Kadokura K, . An Os-1 family histidine kinase from a filamentous fungus confers fungicide-sensitivity to yeast. Curr Genet 2005; 47: 298–306.
   Google Scholar
• Wu Y, Sun YP. Synthesis of nonactin and the proposed structure of trilactone. Org Lett 2006; 8: 2831–2834.
   Google Scholar
• Nett J, Lincoln L, Marchillo K, . Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Ag Chemother 2007; 51: 510–520.
   PubMed Web of Science ®Google Scholar
• Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450–1452.
   PubMed Web of Science ®Google Scholar
• van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005; 73: 7458–7464.
   PubMed Web of Science ®Google Scholar
• Andes D, Nett J, Oschel P, . Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004; 72: 6023–6031.
   PubMed Web of Science ®Google Scholar
• Haneda M, Nawata Y, Hayashi T, Ando K. Tetranactin, a new miticidal antibiotic. VI. Determination of dinactin, trinactin and tetranactin in their mixtures by NMR spectroscopy. J Antibio(Tokyo) 1974; 27: 555–557.
   Google Scholar
• Fleck WF, Ritzau M, Heinze S, Grafe U. Isolation of dimeric nonactic acid from the nonactin-producing Streptomyces spec JA 5909-1. J Basic Microb 1996; 36: 235–238.
   Google Scholar
• Smith LL. An additional source of macrotetrolide antibiotics. J Antibio (Tokyo) 1975; 28: 1000–1003.
   Google Scholar
• Laprade R, Grenier F, Page-Dansereau M, Dansereau J. Carrier- mediated ion transport in lipid bilayer membranes. Can J Biochem Cell Biol 1984; 62: 738–751.
   Google Scholar
• Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008; 9: 551–560.
   PubMed Web of Science ®Google Scholar
• Varma A, Kwon-Chung KJ. Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Ag Chemother 2010; 54: 2303–2311.
   PubMed Web of Science ®Google Scholar
• Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 1999; 48: 671–679.
   PubMed Web of Science ®Google Scholar
• Bisson LF, Coons DM, Kruckeberg AL, Lewis DA. Yeast sugar transporters. Crit Rev Biochem Mol Biol 1993; 28: 259–308.
   PubMed Web of Science ®Google Scholar
• Ando K, Oishi H, Hirano S, Okutomi T, Suzuki K. Tetranactin, a new miticidal antibiotic. I. Isolation, characterization and properties of tetranactin. J Antibio (Tokyo) 1971; 24: 347–352.
   PubMed Web of Science ®Google Scholar
• Stefanac Z, Simon W. Ion Specific electrochemical behavior of macrotetrolides in membranes. Microchem J 1967; 12: 125–132.
   Web of Science ®Google Scholar
• Alijo R, Ramos J. Several routes of activation of the potassium uptake system of yeast. Biochim Biophys Acta 1993; 1179: 224–228.
   Google Scholar
• Zygmunt WA. Intracellular loss of potassium in Candida albicans after exposure to polyene antifungal antibiotics. Appl Microbiol 1966; 14: 953–956.
   Google Scholar
• Hammond SM, Lambert PA, Kliger BN. The mode of action of polyene antibiotics; induced potassium leakage in Candida albicans. J Gen Microbiol 1974; 81: 325–330.
   PubMedGoogle Scholar
• Andes D, Forrest A, Lepak A, . Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Ag Chemother 2006; 50: 2374–2383.
   PubMedGoogle Scholar
• Sanglard D, Kuchler K, Ischer F, . Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Ag Chemother 1995; 39: 2378–2386.
   PubMed Web of Science ®Google Scholar
• Prasad R, De Wergifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Gen 1995; 27: 320–329.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Moran GP, Pinjon E, . Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369–376.
   PubMed Web of Science ®Google Scholar